Evidence map›Paper›PMID 31095595›Full record

ArticlePloS one2019

Assessment of arsenic and polycyclic aromatic hydrocarbon (PAH) exposures on immune function among males in Bangladesh.

Faruque Parvez, Fredine T Lauer, Pam Factor-Litvak, Xinhua Liu, Regina M Santella, Tariqul Islam, Mahbubul Eunus, Nur Alam, Golam Sarwar, Mizanour Rahman and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Effect of polycyclic aromatic hydrocarbons on immunity.Journal of translational autoimmunity · 2022
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Observational
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Faruque ParvezDepartment of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY, United States of America.
Fredine T LauerUniversity of New Mexico College of Pharmacy, Department of Pharmaceutical Sciences, Albuquerque, NM, United States of America.
Pam Factor-LitvakDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, United States of America.
Xinhua LiuDepartment of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY, United States of America.
Regina M SantellaDepartment of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY, United States of America.
Tariqul IslamUniversity of Chicago Field Research Office, Bangladesh.
Mahbubul EunusUniversity of Chicago Field Research Office, Bangladesh.
Nur AlamUniversity of Chicago Field Research Office, Bangladesh.
Golam SarwarUniversity of Chicago Field Research Office, Bangladesh.
Mizanour RahmanUniversity of Chicago Field Research Office, Bangladesh.
Habibul AhsanDepartment of Health Studies, University of Chicago, Chicago, IL, United States of America.
Joseph GrazianoDepartment of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY, United States of America.
Scott W BurchielUniversity of New Mexico College of Pharmacy, Department of Pharmaceutical Sciences, Albuquerque, NM, United States of America.ORCID 0000-0001-9509-0149
Columbia University · USUniversity of Chicago Research Bangladesh · BDUniversity of New Mexico · USUniversity of Chicago · US

Funding

Training CoreP42ES010349 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI NAVAS-ACIEN, ANA · 2000 to 2020
$53.6M
True Metal fac coreP30ES009089 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MATTHEW S PERZANOWSKI · 1998 to 2026
$44.7M
Pilot Program CoreP30ES027792 · NIEHS · UNIVERSITY OF CHICAGO · PI Gokhan M. Mutlu, Gail S Prins · 2017 to 2026
$13.6M
Synergistic Immunosuppression by PAHs and ArseniteR01ES019968 · NIEHS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI BURCHIEL, SCOTT W · 2012 to 2016
$2.9M
Enhancement and Maintenance of the HEALS cohortR24ES028532 · NIEHS · UNIVERSITY OF CHICAGO · PI AHSAN, HABIBUL · 2017 to 2022
$1.7M
Perkin-Elmer NexION-300D Inductively Coupled Mass Spectrometer (ICP-MS)S10OD016384 · OD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GRAZIANO, JOSEPH H · 2014 to 2014
$181k
NIEHS NIH HHS P30 ES009089NIEHS NIH HHS P42 ES010349NIEHS NIH HHS R01 ES019968NIH HHS S10 OD016384
6 · The paper itself

Abstract

Arsenic and polycyclic aromatic hydrocarbons (PAH) are environmental pollutants to which people around the world are exposed through water, food and air. In mouse and in vitro studies of human cells, both of these chemicals have been shown to modulate the immune system. In some experimental studies, a synergistic disruption of immune function was observed by a combined exposure to arsenic and PAH. However, a joint effect of arsenic and PAH on immune function has not been studied in humans. We have conducted an epidemiological investigation to examine effects of chronic arsenic and PAH exposures on immune function. We assessed T-cell proliferation (TCP) and cytokine production of anti-CD3/anti-CD28 stimulated lymphocytes in human peripheral blood mononuclear cells (HPBMC) among 197 healthy men enrolled to the Health Effects of Arsenic Longitudinal (HEALS) cohort in Bangladesh. By design, approximately half were active smokers and the rest were never smokers. Our analyses demonstrated that IL-1b, IL-2, IL-4 and IL-6 were significantly stimulated as a function of urinary arsenic levels in models adjusted for age, body mass index (BMI), smoking status and PAH-DNA adducts. After correcting for false detection rate (FDR), only IL-1b remained statistically significant. We found a U-shaped dose response relationship between urinary arsenic and IL-1b. On the other hand, PAH-DNA adducts were associated with an inhibition of TCP and appeared as an inverted U-shape curve. Dose response curves were non-monotonic for PAH-DNA adduct exposures and suggested that cytokine secretion of IFNg, IL-1b, IL-2, IL-10 and IL17A followed a complex pattern. In the majority of donors, there was a trend towards a decrease in cytokine associated with PAH-DNA adducts. We did not observe any interaction between urinary arsenic and PAH-DNA adducts on immune parameters. Our results indicate that long-term exposures to arsenic and PAH have independent, non-monotonic associations with TCP and cytokine production.

Indexed as

AdultAgedAnimalsArsenicBangladeshDNA AdductsEnvironmental ExposureHumansImmunityMaleMiceMiddle AgedPolycyclic Aromatic HydrocarbonsT-LymphocytesArsenicDNA AdductsPolycyclic Aromatic Hydrocarbons

Identifiers

PMID31095595
PMCPMC6522035
OpenAlexW2946338566

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.